Peripheral Blood Mononuclear Cells, Oral Cancer Remission, Fresh

$960
In stock
SKU
Category: Products
Select SKU Size / Day Price
PBMNC005F-OCR 5 million/vial $960 USD
PBMNC010F-OCR 10 million/vial $1,160 USD
-
+
Questions about shipping? See Shipping Info
Questions? Contact Sales:
530-303-3828
Contact Us
Product Description
Oral Cancer Remission mononuclear cells (MNCs) are separated from peripheral blood by a density gradient centrifugation protocol. MNCs are screened for the expression CD45 and checked for viability using flow cytometry. This highly pure population of cells makes them ideal for further isolations of specific cell types within the mononuclear fraction.

Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.
More Information
Species Human
Disease State Diseased
Cell and Tissue Source Peripheral Blood
Product Type Primary Cells
Cell Type Mononuclear Cells
Donor Attributes Oral Cancer Remission
Viability ≥95% by Flow Cytometry
Format Fresh
Contains PBS with 5% FBS and 0.5% BSA
Anticoagulant EDTA

Product Information Sheet

Material Safety Data Sheet

Hi, have questions?

A StemExpress Expert is happy to help!

Call 530.303.3828 or Contact Us